Sanderling Biomedical Ventures

Sanderling Ventures is a prominent venture capital firm that specializes in early-stage investments within the biomedical and life sciences sectors. Founded in 1979, the firm is known for its proactive investment approach, often taking a lead role in company formation and providing interim management to its portfolio companies. Sanderling's investment portfolio spans biotechnology, medical devices, drug delivery, and healthcare information technology. The firm operates with a focus on identifying and developing platform technologies and breakthrough therapies that address significant unmet medical needs. With a presence in both the United States and Canada, Sanderling leverages its deep industry expertise to guide companies from initial seed funding through clinical development and eventual exit.